Historically, pediatric patients are studied after adult studies are completed and a new drug is approved for adults. During that time, there is often a widespread off-label use of drugs, which sets pediatric patients at risk due to uncertainties in respect to safety, efficacy and appropriate dosing. This continues to place a burden on pediatric patients and their families seeking access to newer therapies. What are some potential solutions to address this important need? Discover the advantages and the prerequisites to enroll adolescents into adult clinical trials during this session.
